CRISPR as a functional cure for hemoglobinopathies
Ugeskrift for Læger · 2025
DOI: 10.61409/v12240888 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ugeskrift for Læger, 2025. Verfasst von Andreas Glenthøj und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dansk Center for Røde Blodceller, Afdeling for Blodsygdomme, Københavns Universitetshospital - Rigshospitalet. Hauptthemen laut MEDLINE: Gene Editing, Hemoglobinopathies, Genetic Therapy, CRISPR-Cas Systems. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Severe haemoglobinopathies, including sickle cell disease and β-thalassaemia, represent significant global health burdens. CRISPR technology enables precise genetic editing of haematopoietic stem cells, with current therapies focused on boosting fetal haemoglobin production for a functional cure. This review finds that, while promising, ex vivo approaches require advanced facilities and substantial resources, limiting accessibility where the need is highest. Future development of in vivo methods may expand global access, addressing the urgent need for scalable and affordable treatments for these debilitating diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dansk Center for Røde Blodceller, Afdeling for Blodsygdomme, Københavns Universitetshospital - Rigshospitalet.
- Institut for Klinisk Medicin, Københavns Universitet.
- Afdeling for Børne og Unge, Københavns Universitetshospital - Rigshospitalet.
- Blodbanken, Klinisk Immunologisk Afdeling, Københavns Universitetshospital - Rigshospitalet.
- Børn og Unge, Aarhus Universitetshospital.
- Institut for Klinisk Medicin, Aarhus Universitet.
Zitieren
APA
Glenthøj, A., Carlsen, S. B. I. S., Hoffmann, M., Haastrup, E. K., Andersen, L. P., Toft, N., Kornblit, B. T., Petersen, J. B., Hasle, H., & Ifversen, M. R. S. (2025). CRISPR as a functional cure for hemoglobinopathies. Ugeskrift for Læger. https://doi.org/10.61409/v12240888
Vancouver
Glenthøj A, Carlsen SBIS, Hoffmann M, Haastrup EK, Andersen LP, Toft N, et al. CRISPR as a functional cure for hemoglobinopathies. Ugeskrift for Læger. 2025. doi:10.61409/v12240888
BibTeX
@article{Glenthj2025,
author = {Glenthøj, Andreas and Carlsen, Sarah Birgitte Ingemod Sand and Hoffmann, Marianne and Haastrup, Eva Kannik and Andersen, Lisbeth Pernille and Toft, Nina and Kornblit, Brian Thomas and Petersen, Jesper Brix and Hasle, Henrik and Ifversen, Marianne Rosenkrantz Segelcke},
title = {CRISPR as a functional cure for hemoglobinopathies},
journal = {Ugeskrift for Læger},
year = {2025},
doi = {10.61409/v12240888}
}
EUVIMED